<p>Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.</p>

Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.

Simvastatin and MS: The Lancet Neurology: August 2017

The Lancet Neurology is a monthly journal, renowned for the publication of high-quality peer-reviewed research, reviews, and analysis from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue, with occasional interviews with an author of a key article.

Share Simvastatin and MS: The Lancet Neurology: August 2017

Sign up to save your podcasts

Simvastatin and MS: The Lancet Neurology: August 2017

Simvastatin and MS: The Lancet Neurology: August 2017